Drug Retention Rate and Predictive Factors of Drug Survival for Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic ArthritisJurgen Sota, Luca Cantarini, Romina Gallizzi et al.|Frontiers in Pharmacology|2019Cited by 616
A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational StudyAntonio Vitale, Luca Cantarini, Chiara Stagnaro et al.|Frontiers in Pharmacology|2016Cited by 88
Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational studyMario Messina, Romina Gallizzi, Chiara Stagnaro et al.|Clinical Rheumatology|2018Cited by 82
Development and initial validation of a composite disease activity score for systemic juvenile idiopathic arthritisJessica Tibaldi, Nicolino Ruperto, Enrico Felici et al.|Lara D. Veeken|2020Cited by 66
Anakinra Drug Retention Rate and Predictive Factors of Long-Term Response in Systemic Juvenile Idiopathic Arthritis and Adult Onset Still DiseaseJurgen Sota, Luca Cantarini, Romina Gallizzi et al.|Frontiers in Pharmacology|2019Cited by 45